hotspot -WSS

hotspot

author：hotspot 2025-09-30 08:01:01 - browse：3

Illustration of a hospital being handed from a doctor to a business person – politics and policy coverage from STAT — New guidelines from federal antitrust enforcers would have big implications on health care deals. Adobe

Health care companies trying to merge can expect tougher policing from the top federal antitrust agencies, according to a set of new draft guidelines released Wednesday.

The Department of Justice and Federal Trade Commission laid out 13 proposed guidelines detailing how they will judge whether proposed mergers and acquisitions are anticompetitive and should be challenged.

The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceutical companies, medical device firms, and numerous other entities occur almost weekly. Research has shown that health care’s highly concentrated markets are a major reason why prices and spending have soared for patients and taxpayers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

WSS

NEJM study link tiny plastics in blood vessels to heart problems

In his State of the Union, Biden takes clear aim at 'Big Pharma'

CDC marks new Covid

Headspace, Meta partner to launch VR meditation app for Quest

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

IVF, abortion rights issues kick off Biden’s State of the Union

focus

hotspot

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

HIV drugs protect against transmission, even in unprotected sex

Virginia high school admissions case could be legal follow

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How to bring more disabled researchers into academia

Hepatitis C has a cure — but many Americans still lack access to it

Ultragenyx gene therapy for rare liver ailment succeeds in late

Malaria cases in Florida and Texas: Here’s what you need to know

Amylyx ALS drug fails large clinical trial

focus

How to bring more disabled researchers into academia

At ASCO, AstraZeneca reports strong data for breast cancer drug

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

The problem with charging patients to message their doctors

At ASCO, AstraZeneca reports strong data for breast cancer drug

entertainment

Wikipedia

entertainment

explore